Physician profile
Robert Smith
NPI 1285663591
$272.14
in general payments reported to CMS, 2019-2025
8 companies · $87.09 in 2025
The $87.09 reported for 2025 was less than what a typical Family Medicine provider received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $57.76 · 2020: $16.40 · 2022: $111 · 2025: $87.09.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $87.09.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $87.09 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Gilead Sciences, INC. | $63.60 | 2022-2025 | |
| Pfizer INC. | $57.76 | 2019 | |
| Ardelyx, INC. | $47.79 | 2025 | Ibsrela |
| Horizon Therapeutics Plc | $28.39 | 2022 | |
| Takeda Pharmaceuticals U.S.A., INC. | $22.48 | 2025 | Eohilia |
| Hikma Pharmaceuticals USA | $21.00 | 2022 | |
| Global Blood Therapeutics, INC. | $16.40 | 2020 | |
| Abbott Laboratories | $14.72 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Robert Smith listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.